BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20598042)

  • 1. Expression of mucin antigens (MUC1 and MUC16) as a prognostic factor for mucinous adenocarcinoma of the uterine cervix.
    Togami S; Nomoto M; Higashi M; Goto M; Yonezawa S; Tsuji T; Batra SK; Douchi T
    J Obstet Gynaecol Res; 2010 Jun; 36(3):588-97. PubMed ID: 20598042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix.
    Kojima A; Mikami Y; Sudo T; Yamaguchi S; Kusanagi Y; Ito M; Nishimura R
    Am J Surg Pathol; 2007 May; 31(5):664-72. PubMed ID: 17460448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study.
    Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Bock JE; Glud E; Nørgaard-Pedersen B; Høgdall CK
    Cancer; 2003 Jul; 98(1):66-73. PubMed ID: 12833457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125).
    Chauhan SC; Singh AP; Ruiz F; Johansson SL; Jain M; Smith LM; Moniaux N; Batra SK
    Mod Pathol; 2006 Oct; 19(10):1386-94. PubMed ID: 16880776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathobiological implications of MUC16/CA125 expression in intrahepatic cholangiocarcinoma-mass forming type.
    Higashi M; Yamada N; Yokoyama S; Kitamoto S; Tabata K; Koriyama C; Batra SK; Yonezawa S
    Pathobiology; 2012; 79(2):101-6. PubMed ID: 22286058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.
    Kim YB; Kim GE; Cho NH; Pyo HR; Shim SJ; Chang SK; Park HC; Suh CO; Park TK; Kim BS
    Cancer; 2002 Aug; 95(3):531-9. PubMed ID: 12209745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer.
    Shibahara H; Higashi M; Koriyama C; Yokoyama S; Kitazono I; Kurumiya Y; Narita M; Kuze S; Kyokane T; Mita S; Arai T; Kato T; Yuasa N; Yamaguchi R; Kubota H; Suzuki H; Baba S; Rousseau K; Batra SK; Yonezawa S
    PLoS One; 2014; 9(4):e86111. PubMed ID: 24722639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder.
    Xiong L; Yang Z; Yang L; Liu J; Miao X
    J Surg Oncol; 2012 Jan; 105(1):97-103. PubMed ID: 21815153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucinous gastric carcinomas: clinicopathologic and molecular analyses.
    Choi JS; Kim MA; Lee HE; Lee HS; Kim WH
    Cancer; 2009 Aug; 115(15):3581-90. PubMed ID: 19479974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma.
    Alfsen GC; Reed W; Sandstad B; Kristensen GB; Abeler VM
    Cancer; 2003 Nov; 98(9):1880-9. PubMed ID: 14584070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
    Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
    Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of p53 and Ki-67 (MIB-1) expressions with clinicopathological features and prognosis of early stage cervical squamous cell carcinomas.
    Hanprasertpong J; Tungsinmunkong K; Chichareon S; Wootipoom V; Geater A; Buhachat R; Boonyapipat S
    J Obstet Gynaecol Res; 2010 Jun; 36(3):572-80. PubMed ID: 20598040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of {beta}-catenin, MUC1 and c-met in diffuse-type gastric carcinomas: correlations with tumour progression and prognosis.
    Retterspitz MF; Mönig SP; Schreckenberg S; Schneider PM; Hölscher AH; Dienes HP; Baldus SE
    Anticancer Res; 2010 Nov; 30(11):4635-41. PubMed ID: 21115917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
    Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
    Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of HER-2/neu is not a risk factor in ovarian clear cell adenocarcinoma.
    Tanabe H; Nishii H; Sakata A; Suzuki K; Mori Y; Shinozaki H; Watanabe A; Ochiai K; Yasuda M; Tanaka T
    Gynecol Oncol; 2004 Sep; 94(3):735-9. PubMed ID: 15350366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors.
    Yeh SA; Wan Leung S; Wang CJ; Chen HC
    Gynecol Oncol; 1999 Jan; 72(1):10-5. PubMed ID: 9889023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44v6 as a prognostic factor in cervical carcinoma FIGO stage IB.
    Bouda J; Boudova L; Hes O; Havir M; Tempfer C; Kohlberger P; Svoboda T; Rokyta Z; Speiser P
    Anticancer Res; 2005; 25(1B):617-22. PubMed ID: 15816636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucin core protein expression by colorectal mucinous carcinomas with or without mucus hyperplasia.
    Ishizu H; Kumagai J; Eishi Y; Takizawa T; Koike M
    J Gastroenterol; 2004; 39(2):125-32. PubMed ID: 15069618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
    Di Saverio S; Gutierrez J; Avisar E
    Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors of adenocarcinoma of the uterine cervix.
    Ishikawa H; Nakanishi T; Inoue T; Kuzuya K
    Gynecol Oncol; 1999 Apr; 73(1):42-6. PubMed ID: 10094878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.